190 - New ID Diagnostics in the Pipeline

Wednesday, October 22, 2025

8:00 AM - 9:00 AM US ET

Location: B302-B304

CME Credits: Maximum of 0 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 0 hours of MOC Credit
CNE Credits: Maximum of 0 hours of ANCC Credit
ACPE Credits: ACPE 0 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 0 of PACE contact hours
CE Broker: Maximum of 0 CE broker credit hours

Moderator(s)

Anne Blaschke, MD, PhD (she/her/hers)

Professor of Pediatrics and Pediatric Infectious Diseases
University of Utah School of Medicine
Salt Lake City, UT, United States
EB

Esther Babady, PhD (she/her/hers)

Chief, Clinical Microbiology Service
Laboratory Medicine
Memorial Sloan Kettering
New York, NY, United States

Disclosure(s):

Anne J. Blaschke, MD, PhD: Biomerieux/Biofire diagnositcs: Grant/Research Support, I have IP owned by the U. of Utah licensed to BioFire and receive royalties.; Delve Bio: Advisor/Consultant; Merck and Company, Inc.: Advisor/Consultant

Esther Babady, PhD: Cepheid, Inc: Honoraria; DiaSorin: Grant/Research Support; Noscendo: Grant/Research Support

Presentations:

8:00 AM - 8:20 AM US ET

ONETest™ PathoGenome: A New Class of Targeted Metagenomic Assay for Diagnosing Infection
Industry Presenter: Sepideh Massoumi Alamouti, PhD (she/her/hers) – Fusion Genomics
8:20 AM - 8:40 AM US ET

Rapid Diagnostics at the Point of Need
Industry Presenter: Samuel Reed, MSc (he/him/his) – DNA Electronics
8:40 AM - 9:00 AM US ET

Rapid MALDI-ToF preparation from Q-linea
Industry Presenter: Vikas Gupta, PharmD (he/him/his) – Q-linea